Abstract We revealed that the stable gastric pentadecapeptide BPC 157, a useful peptide therapy against isoprenaline myocardial infarction, as well as against isoprenaline myocardial reinfarction, may follow the counteraction of the recently described occlusion-like syndrome, induced peripherally and centrally, which was described for the first time in isoprenaline-treated rats
Anemia in neoplastic disease D63.0 applies when the anemia is due to the malignancy itself
This high volume increases contamination risks without consistent sterile practices
Research indicates profound applications across tendon, muscular, and skeletal recovery pathways
Regular intake of high-dose supplements may have carcinogenic potential, especially among smokers
BPC-157 stands for Body Protection Compound-157